Opinion
Video
Author(s):
Yuliya Linhares, MD, discusses the CLL14 study, which is looking at venetoclax plus obinutuzumab in patients with previously untreated chronic lymphocytic leukemia.
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Why Hope is Important For Patients with Chronic Lymphocytic Leukemia
The Treatment Journey of a Patient with CLL
Waiting for Results After My CLL Diagnosis
Learning to ‘Let it Be’ After Poor Test Results